Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Xieli Pharmaceutical, commonly known as Jiangxi Synergy Pharmaceutical, is a leading global manufacturer of plant-derived active pharmaceutical ingredients (APIs). Founded in 1987 and based in Ganzhou, China, the company specializes in the extraction and semi-synthesis of bioflavonoids. Its core product portfolio includes high-purity Rutin, Quercetin, Troxerutin, L-Epicatechin, and Diosmin, serving the pharmaceutical, nutraceutical, and cosmetic industries. The company operates state-of-the-art, GMP-certified manufacturing facilities and is recognized as a National High-tech Enterprise. Xieli Pharma maintains a strong international presence, exporting its products to major markets in Europe, North America, and Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangxi Synergy.